LGALS1/Galectin 1 anticorps
-
- Antigène Voir toutes LGALS1/Galectin 1 (LGALS1) Anticorps
- LGALS1/Galectin 1 (LGALS1) (Lectin, Galactoside-Binding, Soluble, 1 (LGALS1))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LGALS1/Galectin 1 est non-conjugé
-
Application
- Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Whole Mount) (IHC (wm))
- Réactivité croisée
- Humain, Souris, Rat
- Attributs du produit
-
Rabbit Polyclonal antibody to Galectin 1 (lectin, galactoside-binding, soluble, 1)
Galectin 1 antibody - Purification
- Purified by antigen-affinity chromatography.
- Classe de qualité
- KO Validated
- Immunogène
- Recombinant protein encompassing a sequence within the center region of human Galectin 1. The exact sequence is proprietary.
- Isotype
- IgG
- Top Product
- Discover our top product LGALS1 Anticorps primaire
-
-
- Indications d'application
- WB: 1:5000-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IHC-Fr: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: NCI-H929 , BCL-1 , PC-12 , Rat2 , HeLa
Validation: KO/KD, Orthogonal
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.52 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics." dans: Frontiers in immunology, Vol. 11, pp. 1316, (2020) (PubMed).
: "Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008." dans: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 67, (2019) (PubMed).
: "
-
Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics." dans: Frontiers in immunology, Vol. 11, pp. 1316, (2020) (PubMed).
-
- Antigène
- LGALS1/Galectin 1 (LGALS1) (Lectin, Galactoside-Binding, Soluble, 1 (LGALS1))
- Autre désignation
- galectin 1 (LGALS1 Produits)
- Synonymes
- anticorps GAL1, anticorps GBP, anticorps Galectin-1, anticorps LGAS1, anticorps LGALS1, anticorps MGC64502, anticorps GB10026, anticorps AA410090, anticorps Gal-1, anticorps Galbp, anticorps L-14.5, anticorps L14, anticorps Lect14, anticorps galectin-1, anticorps Galaptin, anticorps galectin 1, anticorps galectin-1, anticorps lectin, galactoside-binding, soluble, 1 L homeolog, anticorps protein enabled, anticorps lectin, galactose binding, soluble 1, anticorps LGALS1, anticorps Lgals1, anticorps CC1G_05003, anticorps CC1G_05004, anticorps lgals1.L, anticorps LOC408848
- Sujet
-
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. This gene product may act as an autocrine negative growth factor that regulates cell proliferation.
Cellular Localization: Secreted , extracellular space , extracellular matrix - Poids moléculaire
- 15 kDa
- ID gène
- 3956
- UniProt
- P09382
- Pathways
- Carbohydrate Homeostasis
-